Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

Thank You so much again

First 15914 Last

Share
Profile

Follow
querci

73 Posts.

12

16/05/23

15:45

Post #: 67802461
Share

Originally posted by thevinnys: ↑

Morning all,

It's getting a little difficult to remember all of the updates that are pending from already announced programs/agreements/partnerships.

Due soonish (by the end of June) are previously Incannex published milestones...
IHL-42X - Opening of IND with USA FDA
IHL-42X- Start of Phase2/3 Trial in USA
IHL-675A - Pre-Ind Meeting with USA FDA

Plus....Followups from any of the following..

For all new Shareholders, I have added some links to make it easy for you to check back on the relevant ASX announcement.

>> Update on the PSI-GAD Patent Filing & IP Strategy/Methodology moving forward for PSI treatment/s?
>> Update on GMP Manufacture of Psilocybin for PSI-GAD by Catalent
https://stocknessmonster.com/announcements/ihl.asx-3A614236/

>> Reverse "over liquid" ASX to resolve the "lack of liquidity" on the Nasdaq.
Quote from Joel "volumes on Nasdaq are currently less than on the ASX, we potentially foresee a time whereby this situation is reversed"
https://stocknessmonster.com/announcements/ihl.asx-3A608385/

>> Ethics Committee (HREC) Approval - BA/BE Study IHL-42X (Sleep Apnoea) at C-MAX S.A.
>> Commencement of BA/BE IHL-42X Study...
https://stocknessmonster.com/announcements/ihl.asx-3A607321/

>> Ethics Committee (HREC) Approval - Phase 2 Trial IHL-675A (Rheumatoid Arthritis)

>> Trial Locations / Institutions - Phase 2 IHL-675A (Rheumatoid Arthritis)
"8-10 clinical trial sites across Australia and New Zealand, recruiting 120 patients in total"
https://stocknessmonster.com/announcements/ihl.asx-3A613867/

>> Manufacturing Update from Eurofins re manufacture and test chewable products to alleviate nicotine and opioid addiction.
https://stocknessmonster.com/announcements/ihl.asx-3A608255/
>> CRO Update - Quest Pharmaceutical Services (‘QPS’) to provide regulatory advice and manage clinical trials for the
development of CannQuit™ and ReneCann™ products for addiction and immune-disordered skin diseases.
https://stocknessmonster.com/announcements/ihl.asx-3A616480/

>> Psychedelics - VR agreement/licensing arrangement/extension & and/or other anxiety indications with Monash?
https://stocknessmonster.com/announcements/ihl.asx-3A589013/

>> Manufacturing update from Curia on the inhaled device for IHL-216A
https://stocknessmonster.com/announcements/ihl.asx-3A598294/

>> Clarion Clinics - Update on Abbotsford "Model Clinic" ... location..fitout..premises to be ready before September.....update on supply of psilocybin & MDMA from Pharmala? TGA Requirements.. HREC approval?
https://stocknessmonster.com/announcements/ihl.asx-3A617811/

>> Bob Clarke update later in the year maybe??
Section 10 AGM
https://stocknessmonster.com/announcements/ihl.asx-3A605146/

Good luck to all holders

Expand

Thank You so much again

IHL Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

Time for retail therapy buying in the shopping Scentre for hot stocks

Eurozone-based companies find new ways to secure a regional lithium supply

End of FY is a time to juggle wins, losses and capital gains taxes

SS1

Sun Silver submits US$60M Silver Paste Funding Application to US DoE

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks